0 citations
Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity
Journal of Medicinal Chemistry1991Vol. 34(4), pp. 1408–1414
Citations Over TimeTop 10% of 1991 papers
Claude A. Piantadosi, Canio J. Marasco, Susan L. Morris‐Natschke, K. Meyer, Fatma Gumus, Jefferson R. Surles, Khalid S. Ishaq, Louis S. Kucera, Nathan Iyer
Abstract
Combinations of an amidoalkylphosphocholine, 8, and AZT have been found to cause an apparent synergistic action in suppressing infectious HIV-1 replication. In addition, amidoalkyl, oxyalkyl, and thioalkyl ether lipids have been chemically linked to anti-HIV-1 nucleosides (AZT and DDI) through phosphate and phosphonate linkages. These conjugates have shown promising in vitro anti-HIV-1 activity. Also, the conjugates have a 5-10-fold reduction in cell cytotoxicity compared to AZT alone. The most active compound, an amidoalkyl ether lipid-AZT conjugates, 4A, was found to have a differential selectivity of 1793 in a syncytial plaque assay. In comparison, AZT alone has a value of 1281.
Related Papers
- → Studies of Reversible Conjugate Additions(2013)61 cited
- → Possible enhancing mechanisms for gene transfer activity of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate(2012)22 cited
- → Asymmetric conjugate addition reactions of allyl- and crotylstannanes(2003)22 cited
- → Effects of Some Auxins on IAA-Amino Acid Conjugate Formation in Carrot Tissues Transformed with Ti Plamids.(1993)2 cited
- [Preparation of an insulin conjugate with beta-galactosidase from E. coli for immunoenzyme assay].(1986)